Showing results (1-10 of 39) with videos related to
Sort By:
Pageof 4
Infection and Immunity|March 1, 1978
Evidence for quantitative variability of bacterial opsonic requirementsJ C Guckian, W D Christensen, D P FineJournal of Immunology (Baltimore, Md. : 1950)|May 1, 1978
Trypan blue inhibits complement-mediated phagocytosis by human polymorphonuclear leukocytesJ C Guckian, W D Christensen, D P FineJournal of Immunology (Baltimore, Md. : 1950)|October 1, 1981
Opsonization of pneumococci. II. Metabolic effects of a "third" human serum activity that mediates intracellular killingJ C Guckian, T Cavallo, D P FineThe Journal of Infectious Diseases|August 1, 1980
The role of opsonins in recovery from experimental pneumococcal pneumoniaJ C Guckian, G D Christensen, D P FineImmunology|January 1, 1981
Trypan blue inhibition of complement receptor function on various cellsB L Harper, D P Fine, J C Guckian, et al.The Journal of Laboratory and Clinical Medicine|October 1, 1988
Analysis of humoral and phagocytic defenses against Streptococcus pneumoniae serotypes 1 and 3D P Fine, J L Kirk, G Schiffman, et al.The Journal of Clinical Investigation|September 1, 1980
Complement-independent adherence of Escherichia coli to complement receptors in vitroD P Fine, B L Harper, E D Carpenter, et al.Infection and Immunity|October 1, 1975
Effect of pneumococci on blood clotting, platelets, and polymorphonuclear leukocytesJ C GuckianThe Journal of Infectious Diseases|August 1, 1976
Coagulopathy in experimental sepsis with Streptococcus pneumoniae in rabbits: effect of drug therapy and splenectomyJ C GuckianInfection and Immunity|October 1, 1975
Pneumococcal type-associated variability in alternate complement pathway activationD P FinePageof 4